Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026

The Company will highlight integrated clinical and genomic insights generated through its Oncology Data Solutions platform

NEO : 7.96 (-3.28%)
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack

A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack

NEO : 7.96 (-3.28%)
3 Cash-Burning Stocks We Think Twice About

3 Cash-Burning Stocks We Think Twice About

WTTR : 15.45 (+2.73%)
IEP : 8.06 (+0.06%)
NEO : 7.96 (-3.28%)
NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its first quarter 2026 financial results...

NEO : 7.96 (-3.28%)
3 of Wall Street’s Favorite Stocks We Think Twice About

3 of Wall Street’s Favorite Stocks We Think Twice About

NCNO : 18.23 (-2.51%)
ARRY : 7.57 (-1.17%)
NEO : 7.96 (-3.28%)
2 High-Flying Stocks to Consider Right Now and 1 That Underwhelm

2 High-Flying Stocks to Consider Right Now and 1 That Underwhelm

DRS : 43.20 (-2.35%)
NEO : 7.96 (-3.28%)
BWXT : 216.66 (-5.07%)
3 Russell 2000 Stocks We Approach with Caution

3 Russell 2000 Stocks We Approach with Caution

RUSHA : 73.68 (-1.85%)
NEO : 7.96 (-3.28%)
DBRG : 15.61 (+0.13%)
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

NTRA : 205.42 (-1.12%)
NEO : 7.96 (-3.28%)
AMPH : 21.21 (-7.46%)
NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling

NeoGenomics, Inc. (NASDAQ: NEO) , a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the PanTracer™ LBx test has received coverage from the Centers...

NEO : 7.96 (-3.28%)
3 Reasons to Avoid NEO and 1 Stock to Buy Instead

3 Reasons to Avoid NEO and 1 Stock to Buy Instead

NEO : 7.96 (-3.28%)

Barchart Exclusives

Astera Labs Stock Jumps on Major Amazon-Anthropic Deal. Should You Buy ALAB Here?
Astera stock rallies as Amazon announces a $100 billion partnership expansion with Anthropic. Here’s why this deal is bullish for ALAB shares. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.